Classification of PRSS1 variants responsible for chronic pancreatitis: An expert perspective from the Franco-Chinese GREPAN Study Group

Archive ouverte

Masson, Emmanuelle | Zou, Wen-Bin | Pu, Na | Rebours, Vinciane | Génin, Emmanuelle | Wu, Hao | Lin, Jin-Huan | Wang, Yuan-Chen | Li, Zhao-Shen | Cooper, David | Férec, Claude | Liao, Zhuan | Chen, Jian-Min | Grainville, Thomas | Lièvre, Astrid | Pagenault, Maël | Wallenhorst, Timothée

Edité par CCSD ; Karger -

International audience. BackgroundPRSS1 was the first reported chronic pancreatitis (CP) gene. The existence of both gain-of-function (GoF) and gain-of-proteotoxicity (GoP) pathological PRSS1 variants, together with the fact that PRSS1 variants have been identified in CP subtypes spanning the range from monogenic to multifactorial, has made the classification of PRSS1 variants very challenging.MethodsAll currently reported PRSS1 variants (derived primarily from two databases) were manually reviewed with respect to their clinical genetics, functional analysis and population allele frequency. They were classified by variant type and pathological mechanism within the framework of our recently proposed ACMG/AMP guidelines-based seven-category system.ResultsThe total number of distinct germline PRSS1 variants included for analysis was 100, comprising 3 copy number variants (CNVs), 12 5′ and 3′ variants, 19 intronic variants, 5 nonsense variants, 1 frameshift deletion variant, 6 synonymous variants, 1 in-frame duplication, 3 gene conversions and 50 missense variants. Based upon a combination of clinical genetic and functional analysis, population data and in silico analysis, we classified 26 variants (all 3 CNVs, the in-frame duplication, all 3 gene conversions and 19 missense) as “pathogenic”, 3 variants (missense) as “likely pathogenic”, 5 variants (four missense and one promoter) as “predisposing”, 13 variants (all missense) as “unknown significance”, 2 variants (missense) as “likely benign”, and all remaining 51 variants as “benign”.ConclusionsWe describe an expert classification of the 100 PRSS1 variants reported to date. The results have immediate implications for reclassifying many ClinVar-registered PRSS1 variants as well as providing optimal guidelines/standards for reporting PRSS1 variants.

Suggestions

Du même auteur

Expanding ACMG variant classification guidelines into a general framework

Archive ouverte | Masson, Emmanuelle | CCSD

International audience. Abstract Background The American College of Medical Genetics and Genomics (ACMG)-recommended five variant classification categories (pathogenic, likely pathogenic, uncertain significance, lik...

Toward a clinical diagnostic pipeline for SPINK1 intronic variants

Archive ouverte | Tang, Xin-Ying | CCSD

International audience. Background: The clinical significance of SPINK1 intronic variants in chronic pancreatitis has been previously assessed by various approaches including a cell culture-based full-length gene as...

Splicing Outcomes of 5′ Splice Site GT>GC Variants That Generate Wild-Type Transcripts Differ Significantly Between Full-Length and Minigene Splicing Assays

Archive ouverte | Lin, Jin-Huan | CCSD

International audience. Combining data derived from a meta-analysis of human disease-associated 5′ splice site GT>GC (i.e., +2T>C) variants and a cell culture-based full-length gene splicing assay (FLGSA) of f...

Chargement des enrichissements...